Principal Investigator
Jonathan Trent
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20220980
Clinical Trial Summary
A First-In-Human (FIH) Study Of Idrx-42 In Participants With Metastatic And/Or Unresectable Gastrointestinal Stromal Tumors (GIST)
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Bone and Soft Tissue Cancers
Contact Information
Phone Number
305-243-2647